Sarissa Capital Offshore Master Fund LP 4
4 · Regulus Therapeutics Inc. · Filed May 8, 2020
Insider Transaction Report
Form 4
Transactions
- Other
Warrants to Purchase Common Stock
2020-04-01−23,243→ 1,149,649 totalExercise: $1.08From: 2020-04-01Exp: 2024-05-07→ Common Stock (23,243 underlying) - Other
Class A-2 Convertible Preferred Stock
2020-04-01−5,311→ 262,704 total→ Common Stock (53,110 underlying) - Other
Warrants to Purchase Common Stock
2020-04-01−53,113→ 2,627,037 totalExercise: $0.67From: 2020-04-01Exp: 2024-12-24→ Common Stock (53,113 underlying)
Footnotes (3)
- [F1]See Exhibit 99.1.
- [F2]See Exhibit 99.1.
- [F3]See Exhibit 99.1.